Scarica l'app Stockscreener
148.17
0.39%
-0.58
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AXSM Giù?
Forum
Previsione
Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie
TFG Asset Management GP Ltd Increases Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
RBC Capital Sticks to Its Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail
Axsome Therapeutics, Inc. $AXSM Position Lowered by Eventide Asset Management LLC - MarketBeat
Bellevue Group AG Decreases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Readies Alzheimer’s Drug Launch With Analyst Backing - Finimize
Axsome Confident On Regulatory, Commercial Outlook for Alzheimer's Agitation Drug Candidate, RBC Says - marketscreener.com
9,555 Shares in Axsome Therapeutics, Inc. $AXSM Purchased by WINTON GROUP Ltd - MarketBeat
How Investors Are Reacting To Axsome Therapeutics (AXSM) Revenue Surge Amid Wider Losses and Strategy Shift - Sahm
Axsome Therapeutics, Inc. $AXSM Shares Sold by HighVista Strategies LLC - MarketBeat
Invesco Ltd. Decreases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Russell Investments Group Ltd. Boosts Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Stock Slips On Q4 Profit Miss, But Retail Takes It In Stride - MSN
Hood River Capital Management LLC Acquires Shares of 371,104 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Jump Financial LLC Purchases 35,860 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Price-Driven Insight from (AXSM) for Rule-Based Strategy - news.stocktradersdaily.com
Kennedy Capital Management LLC Boosts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Quantbot Technologies LP Grows Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Norges Bank Acquires New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Schroder Investment Management Group Has $3.91 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Affinity Asset Advisors LLC Has $5.22 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Insider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells 10,558 Shares of Stock - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $7,121,346.68 in Stock - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 20,163 Shares - MarketBeat
Can Axsome Therapeutics Inc. (19X) stock sustain breakout momentum2025 Performance Recap & Fast Entry High Yield Tips - Newser
Will Axsome Therapeutics Inc. stock outperform international peersCEO Change & Smart Money Movement Alerts - Newser
Is Axsome Therapeutics Inc. stock recession proof2025 AllTime Highs & Reliable Trade Execution Plans - Newser
Axsome therapeutics CEO Tabuteau sells $11.6 million in shares By Investing.com - Investing.com South Africa
Axsome therapeutics CEO Tabuteau sells $11.6 million in shares - Investing.com
Will Axsome Therapeutics Inc. (19X) stock outperform small cap peersEarnings Recap Summary & Growth Focused Investment Plans - Newser
Will Axsome Therapeutics Inc. stock outperform value stocksBull Run & Risk Controlled Swing Trade Alerts - Newser
Hsbc Holdings PLC Has $10.24 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Is Axsome Therapeutics Inc. (19X) stock trading at attractive multiplesWeekly Trade Report & High Yield Equity Trading Tips - Newser
Rhumbline Advisers Has $6.45 Million Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What momentum indicators show for Axsome Therapeutics Inc. stockJuly 2025 Action & Risk Managed Trade Strategies - Newser
Is Axsome Therapeutics Inc. (19X) stock included in top ETFsTrade Exit Report & Low Drawdown Trading Strategies - Newser
Axsome (AXSM) Up 5.3% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Granite Investment Partners LLC Has $13.42 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
How Axsome Therapeutics Inc. (19X) stock trades pre earningsJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
Axsome Therapeutics, Inc. $AXSM Shares Purchased by Swiss National Bank - MarketBeat
2 Under-the-Radar Stocks to Buy Heading Into 2026 - sharewise.com
Axsome Therapeutics (AXSM): Evaluating Valuation Following Recent Share Price Momentum and Pipeline Expansion - Yahoo Finance
2 Under-the-Radar Stocks to Buy Heading Into 2026 - The Motley Fool
Axsome Therapeutics, Inc. $AXSM Shares Sold by Loomis Sayles & Co. L P - MarketBeat
Quadrature Capital Ltd Boosts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
2,366 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Elevation Point Wealth Partners LLC - MarketBeat
Capital Fund Management S.A. Buys 47,738 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Jefferies Financial Group Inc. Makes New $261,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
F m Investments LLC Takes $3.36 Million Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM Shares Sold by PNC Financial Services Group Inc. - MarketBeat
Is Axsome Therapeutics Inc a good long term investmentHigh Dividend Yield Stocks & Free Turn Volatility To Profit - earlytimes.in
Axsome Therapeutics Stock (AXSM) Opinions on Recent Revenue Surge - Quiver Quantitative
Franklin Resources Inc. Acquires 51,995 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):